top menu action banner

ARIXTRA (FONDAPARINUX SODIUM) 2.5MG 0.5ML PFS 10`S

Ksh 30,499

In Stock

  • Product Categories:

WHAT IS THIS MEDICINE AND WHAT IS IT USED FOR?

Arixtra contains fondaparinux sodium, a medicine that thins the blood to prevent blood clots (called deep vein thrombosis or DVT) from forming in your veins after surgery. The 2.5 mg dose is the standard preventive (prophylactic) dose given to patients who have had hip fracture surgery, hip replacement, knee replacement, or major abdominal surgery — times when you are at high risk of clots because you are less mobile.

 

3. HOW TO TAKE THIS MEDICINE

This medicine is injected under the skin (subcutaneously) into the fat around your stomach (abdomen). You will receive your first injection at least 6–8 hours after your surgery, once any bleeding has been controlled. After that, you have one injection every day, usually for 5–9 days. For hip fracture surgery, the course may continue for up to 32 days in total. A nurse or pharmacist will show you how to inject it yourself if you are going home with it.

 

💡 PATIENT TIP: This 2.5 mg preventive dose is not suitable if your kidneys are working poorly (creatinine clearance below 30 mL/min) — your doctor will decide on an alternative. It is also not recommended if you weigh less than 50 kg. Elderly patients may need closer monitoring as kidney function naturally declines with age.

 

4. POSSIBLE SIDE EFFECTS

How Common?

Side Effects to Know About

Common (>1 in 10)

Bruising or mild bleeding at the injection site, mild anaemia (low red blood cells) after surgery, swelling, nausea

Less Common

Low platelet count (thrombocytopenia), raised liver enzymes, skin rash or itching, low potassium levels

Seek Medical Help

Serious bleeding (including internal bleeding) — seek emergency help immediately if you notice unusual bruising, blood in urine or stools, or vomiting blood. Back pain with leg weakness or loss of bladder/bowel control after spinal anaesthesia may indicate a rare but serious spinal blood clot.

 

5. WHO SHOULD NOT TAKE THIS MEDICINE

Do not use if: you have severe kidney disease (CrCl <30 mL/min), you are actively bleeding heavily, you have a heart valve infection (bacterial endocarditis), your platelet count has dropped due to a reaction to fondaparinux, you weigh less than 50 kg (for prevention use), or you are allergic to fondaparinux.

 

IMPORTANT SAFETY INFORMATION: SPINAL BLOOD CLOTS: If you are having an epidural or spinal injection alongside this medicine, there is a small risk of a blood clot forming around the spinal cord. This can cause permanent paralysis. Report any back pain, weakness in your legs, or loss of bladder or bowel control to your doctor immediately. NO ANTIDOTE: There is no specific reversal agent for fondaparinux, unlike some other blood thinners. LATEX ALLERGY: The needle guard of the syringe contains natural rubber — tell your doctor if you have a latex allergy.

 

6. MEDICINES THAT INTERACT WITH THIS TREATMENT

Taking fondaparinux with other blood-thinning medicines — including aspirin, ibuprofen and other NSAIDs, clopidogrel, warfarin, or newer anticoagulants like rivaroxaban — significantly increases the risk of serious bleeding. Your doctor should review all your medicines before starting Arixtra.

 

7. HOW TO STORE THIS MEDICINE

Store at room temperature (15°C–30°C). Do not freeze. Keep in the original packaging. Each syringe is single-use — discard after one injection.

 

8. PRESCRIPTION REQUIREMENT

Status

Prescription Only Medicine (POM)

 

9. GUIDANCE FOR PATIENTS & CAREGIVERS

This injection helps protect you from a serious and potentially fatal blood clot after your surgery. Inject into the fatty skin of your lower abdomen, away from your navel. Rotate injection sites and do not rub the area after injecting. Report any unusual bleeding or bruising, dark/bloody stools, severe headache, sudden weakness, or back pain to your doctor or go to the emergency room. Tell every healthcare provider you see — including dentists — that you are taking a blood thinner.

 

10. PHARMACIST & PRESCRIBER NOTES

Clinical Dispensing Notes

Confirm strength: 2.5 mg is the prophylactic (prevention) dose only. Not for DVT treatment — see 7.5 mg strength. Verify weight (contraindicated <50 kg for prophylaxis) and renal function before dispensing. Educate on subcutaneous injection technique and correct abdominal site rotation. Latex needle guard — screen for latex allergy. Monitor platelet count and signs of bleeding.

 

11. FREQUENTLY ASKED QUESTIONS

Q: How do I inject Arixtra at home?

A: Pinch a fold of skin on your lower abdomen (at least 5 cm from your navel). Insert the needle straight in at a 90-degree angle and press the plunger slowly. Do not rub the area after injecting. Rotate injection sites each day. Your nurse or pharmacist can demonstrate the technique.

Q: How long do I need to use Arixtra injections?

A: For most surgeries, Arixtra is given for 5–9 days. For hip fracture surgery, your doctor may extend the course for up to 32 days to protect you during your longer recovery period.

Q: Can I eat normally while taking Arixtra?

A: Yes — unlike warfarin, Arixtra does not have food interactions. However, avoid taking other blood-thinning medicines (including aspirin and ibuprofen) without your doctor's approval, as this increases bleeding risk.

Q: What should I do if I miss an injection?

A: If you miss a daily dose and remember on the same day, inject as soon as you can. If you miss an entire day, do not double the next day's dose — contact your doctor or nurse for advice.

Q: How do I store Arixtra pre-filled syringes?

A: Store at room temperature (15–30°C) away from heat and direct light. Do not freeze. Each syringe is single-use — dispose of safely in a sharps bin after each injection.

 

Customer Feedback


Recently Viewed